{
  "event_id": "79fd12666885",
  "ticker": "BIIB",
  "company_name": "Biogen",
  "drug_name": "Lecanemab",
  "result": "approved",
  "pdufa_date": "2025-08-29",
  "approval_type": {
    "status": "found",
    "value": "bla",
    "source": "websearch:CLARITY AD Phase 3, NEJM 2023",
    "confidence": 0.9,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.196306",
    "error": null
  },
  "indication": {
    "status": "found",
    "value": "Early Alzheimer's Disease",
    "source": "websearch:CLARITY AD Phase 3, NEJM 2023",
    "confidence": 0.85,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.196308",
    "error": null
  },
  "generic_name": {
    "status": "found",
    "value": "lecanemab-irmb",
    "source": "websearch_fda",
    "confidence": 0.85,
    "tier": 2,
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-10T07:18:32.440880",
    "error": null
  },
  "therapeutic_area": {
    "status": "found",
    "value": "Neurology",
    "source": "websearch",
    "confidence": 0.85,
    "tier": 2,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-10T10:49:58.561618",
    "error": null
  },
  "mechanism_of_action": {
    "status": "found",
    "value": "Anti-amyloid antibody",
    "source": "legacy_migration",
    "confidence": 0.75,
    "tier": 3,
    "evidence": [],
    "searched_sources": [
      "legacy_v12"
    ],
    "last_searched": "2026-01-10T12:42:32.143055",
    "error": null,
    "note": null
  },
  "phase": {
    "status": "found",
    "value": "Approved",
    "source": "websearch_clinical",
    "confidence": 0.85,
    "tier": 2,
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-10T07:18:32.440880",
    "error": null
  },
  "primary_endpoint_met": {
    "status": "found",
    "value": true,
    "source": "websearch:CLARITY AD Phase 3, NEJM 2023",
    "confidence": 0.95,
    "evidence": [
      "CLARITY AD Phase 3, NEJM 2023"
    ],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.196294",
    "error": null
  },
  "p_value": {
    "status": "found",
    "value": "0.00005",
    "source": "websearch:CLARITY AD Phase 3, NEJM 2023",
    "confidence": 0.9,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.196300",
    "error": null
  },
  "effect_size": {
    "status": "found",
    "value": "27% slowing of decline (CDR-SB -0.45)",
    "source": "websearch:CLARITY AD Phase 3, NEJM 2023",
    "confidence": 0.85,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.196303",
    "error": null
  },
  "has_prior_crl": {
    "status": "found",
    "value": false,
    "source": "derived_from_first_submission",
    "confidence": 0.95,
    "tier": 2
  },
  "is_resubmission": {
    "status": "found",
    "value": 0,
    "source": "legacy_v12",
    "confidence": 0.75,
    "evidence": [],
    "searched_sources": [
      "legacy_v12"
    ],
    "last_searched": null,
    "error": null
  },
  "pai_passed": {
    "status": "found",
    "value": true,
    "source": "derived_from_approval",
    "confidence": 0.95,
    "tier": 1,
    "note": "Approved drugs must have passed PAI"
  },
  "warning_letter": {
    "status": "found",
    "value": false,
    "source": "inferred_from_approval",
    "confidence": 0.8,
    "tier": 2,
    "note": "Approved drugs unlikely to have blocking warning letters"
  },
  "safety_signal": {
    "status": "found",
    "value": true,
    "source": "known_safety_database",
    "confidence": 0.95,
    "tier": 1,
    "reason": "ARIA risk",
    "severity": "medium"
  },
  "p_value_numeric": 5e-05,
  "nct_ids": [
    "NCT03887455",
    "NCT04468659"
  ],
  "phase3_study_names": [
    "A Placebo-Controlled, Double-Blind, Parallel-Group, 18-Month Study With an Open-Label Extension Phase to Confirm Safety and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease",
    "AHEAD 3-45 Study: A Placebo-Controlled, Double-Blind, Parallel-Treatment Arm, 216 Week Study With an Extension Phase to Evaluate Efficacy and Safety of Treatment With BAN2401 in Subjects With Preclinical Alzheimer's Disease and Elevated Amyloid (A45 Trial) and in Subjects With Early Preclinical Alzheimer's Disease and Intermediate Amyloid (A3 Trial)"
  ],
  "prior_crl_reason": null,
  "enrollment": {
    "value": 1906,
    "status": "found",
    "source": "clinicaltrials.gov",
    "confidence": 0.95,
    "tier": 2
  },
  "fda_designations": {
    "breakthrough_therapy": true,
    "fast_track": true,
    "priority_review": true,
    "orphan_drug": false,
    "accelerated_approval": true
  },
  "adcom_info": {
    "scheduled": true,
    "held": true,
    "date": null,
    "outcome": "favorable",
    "vote_for": null,
    "vote_against": null
  },
  "is_single_arm": {
    "value": false,
    "status": "found",
    "source": "clinicaltrials.gov",
    "confidence": 0.95,
    "tier": 2,
    "evidence": [
      "interventionModel=PARALLEL",
      "allocation=RANDOMIZED"
    ],
    "searched_sources": [
      "clinicaltrials.gov"
    ],
    "last_searched": "2026-01-11T08:29:41.589383",
    "error": null,
    "note": null,
    "has_value": true,
    "needs_retry": false,
    "is_complete": true
  },
  "trial_region": {
    "value": "global",
    "status": "found",
    "source": "clinicaltrials.gov",
    "confidence": 0.95,
    "tier": 2,
    "evidence": [
      "countries=['SPAIN', 'UNITED KINGDOM', 'SOUTH KOREA', 'JAPAN', 'SWEDEN']..."
    ],
    "searched_sources": [
      "clinicaltrials.gov"
    ],
    "last_searched": "2026-01-11T08:29:41.589440",
    "error": null,
    "note": null,
    "has_value": true,
    "needs_retry": false,
    "is_complete": true
  },
  "is_biosimilar": {
    "value": true,
    "status": "found",
    "source": "suffix_pattern",
    "confidence": 0.85,
    "tier": 3,
    "evidence": [
      "suffix match: lecanemab-irmb"
    ],
    "searched_sources": [
      "suffix_pattern"
    ],
    "last_searched": "2026-01-10T13:11:17.415163",
    "error": null,
    "note": null,
    "has_value": true,
    "needs_retry": false,
    "is_complete": true
  },
  "is_first_in_class": {
    "status": "not_searched",
    "value": null,
    "source": "",
    "confidence": 0.0,
    "tier": null,
    "evidence": [],
    "searched_sources": [],
    "last_searched": null,
    "error": null,
    "note": null
  },
  "crl_reason_type": {
    "status": "not_searched",
    "value": null,
    "source": "",
    "confidence": 0.0,
    "tier": null,
    "evidence": [],
    "searched_sources": [],
    "last_searched": null,
    "error": null,
    "note": null
  },
  "warning_letter_date": {
    "value": null,
    "status": "confirmed_none",
    "source": "websearch_fda",
    "confidence": 0.8,
    "tier": 2,
    "evidence": [],
    "searched_sources": [
      "websearch_fda"
    ],
    "last_searched": "2026-01-11T04:05:14.854707",
    "error": null,
    "note": "No manufacturing warning letters found 2023-2025"
  },
  "fda_483_date": {
    "value": "2022-11-01",
    "status": "found",
    "source": "news",
    "confidence": 0.8,
    "tier": 3,
    "evidence": [
      "Facility: RTP, NC",
      "Outcome: N/A"
    ],
    "searched_sources": [
      "news"
    ],
    "last_searched": "2026-01-11T05:25:26.304995",
    "error": null,
    "facility": "RTP, NC"
  },
  "fda_483_observations": {
    "status": "not_searched",
    "value": null,
    "source": "",
    "confidence": 0.0,
    "tier": null,
    "evidence": [],
    "searched_sources": [],
    "last_searched": null,
    "error": null,
    "note": null
  },
  "cdmo_name": {
    "status": "not_searched",
    "value": null,
    "source": "",
    "confidence": 0.0,
    "tier": null,
    "evidence": [],
    "searched_sources": [],
    "last_searched": null,
    "error": null,
    "note": null
  },
  "pai_date": {
    "value": null,
    "status": "not_found",
    "source": "",
    "confidence": 0.0,
    "tier": null,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-10T13:34:33.234879",
    "error": null,
    "note": null,
    "has_value": false,
    "needs_retry": true,
    "is_complete": false
  },
  "clinical_hold_history": {
    "value": null,
    "status": "confirmed_none",
    "source": "websearch_clinical_hold",
    "confidence": 0.0,
    "tier": null,
    "evidence": [],
    "searched_sources": [
      "websearch_clinical_hold"
    ],
    "last_searched": "2026-01-10T13:34:34.212348",
    "error": null,
    "note": null,
    "has_value": false,
    "needs_retry": false,
    "is_complete": true
  },
  "days_to_pdufa": -134,
  "pdufa_status": "past",
  "risk_tier": "HIGH",
  "days_calculated_at": "2026-01-10T16:59:38.101696",
  "original_case_id": "959a60478e67",
  "data_quality_score": 0.075,
  "collected_at": "2026-01-09T00:30:21.510228",
  "enriched_at": "2026-01-11T17:59:07.207144",
  "needs_manual_review": false,
  "review_reasons": [],
  "migrated_at": "2026-01-10T12:42:32.143079",
  "schema_version": "3.0",
  "adcom_scheduled": {
    "value": true,
    "status": "found",
    "source": "websearch_adcom",
    "confidence": 0.75,
    "tier": 3,
    "evidence": [
      "FDA Advisory Panel Votes in Favor of Full Approval for Lecanemab",
      "FDA Advisory Committee endorses traditional approval of ...",
      "FDA Panel Backs Traditional Approval of Lecanemab for ..."
    ],
    "searched_sources": [
      "websearch_adcom"
    ],
    "last_searched": "2026-01-11T08:24:09.906305"
  },
  "adcom_vote_ratio": {
    "value": null,
    "status": "not_found",
    "source": "websearch_adcom",
    "confidence": 0.6,
    "tier": 3,
    "evidence": [],
    "searched_sources": [
      "websearch_adcom"
    ],
    "last_searched": "2026-01-11T08:24:09.906314"
  },
  "breakthrough_therapy": {
    "value": true,
    "status": "found",
    "source": "websearch",
    "confidence": 0.75,
    "tier": 2,
    "evidence": [
      "Lecanemab Wins Breakthrough Designation for Alzheimer Disease Lecanemab wins breakthrough therapy de"
    ],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T17:58:56.899903",
    "search_status": "FOUND"
  },
  "priority_review": {
    "value": true,
    "status": "found",
    "source": "websearch",
    "confidence": 0.75,
    "tier": 2,
    "evidence": [
      "Priority Review Granted for Lecanemab by FDA - - Practical ..."
    ],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T17:59:04.813589",
    "search_status": "FOUND"
  },
  "fast_track": {
    "value": true,
    "status": "found",
    "source": "websearch",
    "confidence": 0.75,
    "tier": 2,
    "evidence": [
      "Rolling FDA License Application for LEQEMBI Autoinjector ..."
    ],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T17:59:06.002441",
    "search_status": "FOUND"
  },
  "orphan_drug": {
    "value": null,
    "status": "not_found",
    "source": "websearch",
    "confidence": 0.0,
    "tier": 3,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T17:59:03.768650",
    "search_status": "CONFIRMED_NONE"
  },
  "accelerated_approval": {
    "value": true,
    "status": "found",
    "source": "websearch",
    "confidence": 0.95,
    "tier": 2,
    "evidence": [
      "FDA Grants Accelerated Approval for Alzheimerâ€™s Disease ..."
    ],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T17:59:07.207132",
    "search_status": "FOUND"
  }
}